Schoeneck James A
Director at FGEN; President and CEO at DEPOMED INC
- Sold, on record
- $2.4M
- Dollars the filings state
- Form 4 sales
- 11
- Latest Jun 7, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- FGENKYNTRA BIO, INC.Director
- DEPOMED INCPresident and CEO
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- DEPOMED INC70,919 shares
- FGEN29,100 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale FGENUnusualJul 3, 2018 2018
Sold 7,639 shares at $65.00 ($497k)
Schoeneck James A, Director
Sold 67.4% of holdings ($737k position)3,700 shares leftFiling
- 2 Form 4 sale FGENPlan not statedJan 7, 2019 +188 days
Sold 2,000 shares at $45.90 ($92k)
Schoeneck James A, Director
Sold 6.7% of holdings ($1.4M position)27,700 shares leftFiling
- 3 Form 4 sale FGENPlan not statedFeb 7, 2019 +31 days
Sold 2,000 shares at $57.17 ($114k)
Schoeneck James A, Director
Sold 6.7% of holdings ($1.7M position)27,700 shares left0.5x usual sizeFiling
- 4 Form 4 sale FGENPlan not statedMar 7, 2019 +28 days
Sold 2,000 shares at $54.74 ($109k)
Schoeneck James A, Director
Sold 6.7% of holdings ($1.6M position)27,700 shares left0.6x usual sizeFiling
- 5 Form 4 sale FGENPlan not statedApr 8, 2019 +32 days
Sold 2,000 shares at $52.90 ($106k)
Schoeneck James A, Director
Sold 6.7% of holdings ($1.6M position)27,700 shares left1x usual sizeFiling
- 6 Form 4 sale FGENUnusualMay 7, 2019 +29 days
Sold 2,000 shares at $47.02 ($94k)
Schoeneck James A, Director
Sold 35.1% of holdings ($268k position)3,700 shares left1x usual sizeFiling
- 7 Form 144 notice FGENNoticeJun 7, 2023 +1492 days
Filed to sell 7,100 shares ($128k)
Schoeneck James A, Director
10b5-1 planFirst sale on recordFiling
- 8 Form 4 sale FGENRoutineJun 7, 2023 same day
Sold 7,100 shares at $18.03 ($128k)
Schoeneck James A, Director
10b5-1 planSold 8.8% of holdings ($1.5M position)73,722 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | Jun 9, 2023 | FGEN | Director | Form 4 sale | 7,100 | $128k | 8.8% | Routine | SEC |
| Jun 7, 2023 | Jun 7, 2023 | FGEN | Director | Form 144 notice | 7,100 | $128k | Notice | SEC | |
| May 7, 2019 | May 9, 2019 | FGEN | Director | Form 4 sale | 2,000 | $94k | 35.1% | Unusual | SEC |
| Apr 8, 2019 | Apr 10, 2019 | FGEN | Director | Form 4 sale | 2,000 | $106k | 6.7% | Plan not stated | SEC |
| Mar 7, 2019 | Mar 8, 2019 | FGEN | Director | Form 4 sale | 2,000 | $109k | 6.7% | Plan not stated | SEC |
| Feb 7, 2019 | Feb 8, 2019 | FGEN | Director | Form 4 sale | 2,000 | $114k | 6.7% | Plan not stated | SEC |
| Jan 7, 2019 | Jan 9, 2019 | FGEN | Director | Form 4 sale | 2,000 | $92k | 6.7% | Plan not stated | SEC |
| Jul 3, 2018 | Jul 6, 2018 | FGEN | Director | Form 4 sale | 7,639 | $497k | 67.4% | Unusual | SEC |
| Jun 22, 2018 | Jun 26, 2018 | FGEN | Director | Form 4 sale | 4,361 | $283k | 54.1% | Unusual | SEC |
| Dec 2, 2014 | Dec 3, 2014 | DEPOMED INC | President and CEO | Form 4 sale | 36,727 | $582k | 41.0% | Unusual | SEC |
| Mar 14, 2014 | Mar 14, 2014 | DEPOMED INC | President and CEO | Form 4 sale | 17,000 | $247k | 14.6% | Plan not stated | SEC |
| Dec 2, 2013 | Dec 4, 2013 | DEPOMED INC | President and CEO | Form 4 sale | 17,192 | $144k | 12.9% | Plan not stated | SEC |